Privacy-Maintaining Propensity Score-Based Pooling of Multiple Databases Applied to a Study of Biologics

被引:28
作者
Rassen, Jeremy A. [1 ]
Solomon, Daniel H. [2 ]
Curtis, Jeffrey R. [3 ]
Herrinton, Lisa [4 ]
Schneeweiss, Sebastian
机构
[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon,Dept Med, Boston, MA 02120 USA
[2] Brigham & Womens Hosp, Dept Med, Div Rheumatol, Boston, MA 02115 USA
[3] Univ Alabama Birmingham, Dept Med, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA
[4] Kaiser Permanente, Div Res, Oakland, CA USA
关键词
propensity scores; confounding factors (epidemiology); multicenter study [publication type; privacy; epidemiologic methods; CLOPIDOGREL;
D O I
10.1097/MLR.0b013e3181d59541
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Introduction: A large study on the safety of biologics required pooling of data from multiple data sources, but while extensive confounder adjustment was necessary, private, individual-level covariate information could not be shared. Objectives: To describe the methods of pooling data that investigators considered, and to detail the strengths and limitations of the chosen method: a propensity score (PS)-based approach that allowed for full multivariate adjustment without compromising patient privacy. Research Design: The project had a central data coordinating center responsible for collection and analysis of data. Private data could not be transmitted to the data coordinating center. Investigators assessed 4 methods for pooled analyses: full covariate sharing, cell-aggregated sharing, meta-analysis, and the PS-based method. We evaluated each method for protection of private information, analytic integrity and flexibility, and ability to meet the study's operational and statistical needs. Results: Analysis of 4 example datasets yielded substantially similar estimates if data were pooled with a PS versus individual covariates (0%-3% difference in point estimates). Several practical challenges arose. (1) PSs are best suited for dichotomous exposures but 6 or more exposure categories were desired; we chose a series of exposure contrasts with a common referent group. ( 2) Subgroup analyses had to be specified a priori. (3) Time-varying exposures and confounders required appropriate analytic handling including re-estimation of PSs. ( 4) Detection of heterogeneity among centers was necessary. Conclusions: The PS-based pooling method offered strong protection of patient privacy and a reasonable balance between analytic integrity and flexibility of study execution. We would recommend its use in other studies that require pooling of databases, multivariate adjustment, and privacy protection.
引用
收藏
页码:S83 / S89
页数:7
相关论文
共 22 条
[1]  
Agresti A., 1990, CATEGORICAL DATA ANA
[2]  
[Anonymous], 2008, Modern epidemiology
[3]   Confounder summary scores when comparing the effects of multiple drug exposures [J].
Cadarette, Suzanne M. ;
Gagne, Joshua J. ;
Solomon, Daniel H. ;
Katz, Jeffrey N. ;
Stuermer, Til .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 (01) :2-9
[4]   METAANALYSIS IN CLINICAL-TRIALS [J].
DERSIMONIAN, R ;
LAIRD, N .
CONTROLLED CLINICAL TRIALS, 1986, 7 (03) :177-188
[5]   Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin [J].
Gilard, Martine ;
Arnaud, Bertrand ;
Cornily, Jean-Christophe ;
Le Gal, Gregoire ;
Lacut, Karine ;
Le Calvez, Genevive ;
Mansourati, Jacques ;
Mottier, Dominique ;
Abgrall, Jean-Francois ;
Boschat, Jacques .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (03) :256-260
[6]   Indications for propensity scores and review of their use in pharmacoepidemiology [J].
Glynn, RJ ;
Schneeweiss, S ;
Stürmer, T .
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2006, 98 (03) :253-259
[7]   Risk of Adverse Outcomes Associated With Concomitant Use of Clopidogrel and Proton Pump Inhibitors Following Acute Coronary Syndrome [J].
Ho, P. Michael ;
Maddox, Thomas M. ;
Wang, Li ;
Fihn, Stephan D. ;
Jesse, Robert L. ;
Peterson, Eric D. ;
Rumsfeld, John S. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 301 (09) :937-944
[8]  
Hosmer W., 2000, Applied Logistic Regression, VSecond
[9]   A population-based study of the drug interaction between proton pump inhibitors and clopidogrel [J].
Juurlink, David N. ;
Gomes, Tara ;
Ko, Dennis T. ;
Szmitko, Paul E. ;
Austin, Peter C. ;
Tu, Jack V. ;
Henry, David A. ;
Kopp, Alex ;
Mamdani, Muhammad M. .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2009, 180 (07) :713-718
[10]   Multicenter epidemiologic and health services research on therapeutics in the HMO Research Network Center for Education and Research on Therapeutics [J].
Platt, R ;
Davis, R ;
Finkelstein, J ;
Go, AS ;
Gurwitz, JH ;
Roblin, D ;
Soumerai, S ;
Ross-Degnan, D ;
Andrade, S ;
Goodman, MJ ;
Martinson, B ;
Raebel, MA ;
Smith, D ;
Ulcickas-Yood, M ;
Chan, KA .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2001, 10 (05) :373-377